Literature DB >> 1907531

Recombinant interferon-gamma inhibits the expression of IL-4 receptors on human lymphocytes.

K A Byron1, G A Varigos, A M Wootton.   

Abstract

Interferon gamma (IFN-gamma) has been shown to inhibit many of the activities of IL-4, including the induction of IgE synthesis and the proliferation of T cell clones. Here we demonstrate that IFN-gamma is able to inhibit the expression of IL-4 receptors on peripheral blood lymphocytes from both normal healthy donors and from patients with chronic lymphocytic leukaemia. Inhibition was shown to be dose-dependent and did not affect the binding affinity of the receptor as shown by Scatchard analysis. IFN-gamma was unable to displace labelled IL-4 from its membrane receptor, which demonstrates that IFN-gamma and IL-4 do not compete for the same membrane binding protein. The ability of IFN-gamma to down-regulate IL-4 receptors may be important in controlling certain immune responses.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907531      PMCID: PMC1535746          DOI: 10.1111/j.1365-2249.1991.tb05724.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Regulation of T-cell activation: differences among T-cell subsets.

Authors:  T F Gajewski; S R Schell; G Nau; F W Fitch
Journal:  Immunol Rev       Date:  1989-10       Impact factor: 12.988

2.  Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.

Authors:  C E Zuber; J P Galizzi; A Vallé; N Harada; M Howard; J Banchereau
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

3.  Iodination of biological samples without loss of functional activity.

Authors:  F Tejedor; J P Ballesta
Journal:  Anal Biochem       Date:  1982-11-15       Impact factor: 3.365

4.  Establishment of different T cell sublines using either interleukin 2 or interleukin 4 as growth factors.

Authors:  E Schmitt; R Van Brandwijk; H G Fischer; E Rüde
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

5.  Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells.

Authors:  N A Nicola; D Metcalf
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

6.  Interleukin 4 is a growth factor for activated thymocytes: possible role in T-cell ontogeny.

Authors:  A Zlotnik; J Ransom; G Frank; M Fischer; M Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

7.  Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).

Authors:  J Pène; I Chrétien; F Rousset; F Brière; J Y Bonnefoy; J E de Vries
Journal:  J Cell Biochem       Date:  1989-03       Impact factor: 4.429

8.  A cell culture system that enhances mononuclear cell IgE synthesis induced by recombinant human interleukin-4.

Authors:  J L Claassen; A D Levine; R H Buckley
Journal:  J Immunol Methods       Date:  1990-02-09       Impact factor: 2.303

9.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.

Authors:  J Bujanowski-Weber; B Brings; I Knöller; T Pfeil; W König
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.